Related Experiment Video
Updated: May 20, 2025

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
Published on: March 3, 2023
Dressing antibacterial platinum loaded polyurethane materials by a stable hydrophilic coating with robust
Shuai Gao1,2, Zheng Liu2, Wei Zeng2
1National Engineering Research Center for Biomaterials, College of Biomedical Engineering, Sichuan University, Chengdu 610064, People's Republic of China.
Abstract:
Thrombus formation and infection resulting from blood contact with medical materials represent significant clinical complications characterized by a mutually reinforcing relationship between the two phenomena. Consequently, the development of hydrophilic coatings that simultaneously release bactericidal agents and exhibit passive antithrombotic properties is of paramount importance. In this work, we employed a straightforward, easily executable, and amenable to scale-up strategy to synthesize an antibacterial polyurethane matrix containing platinum complex, followed by the construction of a phosphorylcholine-based hydrophilic coating on its surface via surface-initiated polymerization. The antibacterial efficacy arises from the sustained release mechanism of platinum complex ions, while the phosphorylcholine coating exhibits remarkable antithrombotic characteristics. These two functionalities operate both independently and synergistically within the material to provide robust antibacterial and antithrombotic performance.In vitroandin vivoexperiments validated the effectiveness of this composite material in inhibiting bacterial growth and preventing thrombus formation. Furthermore, histological analysis along with immunological detection confirmed that the coating material has excellent biocompatibility coupled with anti-inflammatory effects. Therefore, the developed innovative coating with efficient antibacterial and antithrombotic effects shows great promise as an effective strategy for mitigating risks associated with infections and thrombus formation in clinical settings involving blood-contacting medical devices and related implants.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hand hygiene
Hand washing...

